103 related articles for article (PubMed ID: 1884674)
1. [Methotrexate in the therapy of primary biliary cirrhosis].
Weber P; Scheurlen M; Wiedmann KH
Dtsch Med Wochenschr; 1991 Sep; 116(36):1347-52. PubMed ID: 1884674
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
[TBL] [Abstract][Full Text] [Related]
3. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
5. Primary biliary cirrhosis (PBC): is effective therapy now at hand?
Kaplan MM; Knox TA; Arora S
Trans Assoc Am Physicians; 1988; 101():193-202. PubMed ID: 3269678
[No Abstract] [Full Text] [Related]
6. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate therapy in primary biliary cirrhosis.
Sordá J; Findor J
Acta Gastroenterol Latinoam; 2000; 30(4):221-5. PubMed ID: 11086511
[TBL] [Abstract][Full Text] [Related]
8. Natural history of pruritus in primary biliary cirrhosis.
Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
[TBL] [Abstract][Full Text] [Related]
9. Therapy of primary biliary cirrhosis with p-tolylmethylcarbinol nicotinic acid ester in combination with alpha-naphthylacetic acid.
Kaserbacher R; Propst A; Vogel W
Wien Klin Wochenschr; 1996 Nov; 108(22):722-6. PubMed ID: 8986034
[TBL] [Abstract][Full Text] [Related]
10. [The treatment of primary biliary cirrhosis with ursodeoxycholic acid. The short- and median-term results and their relation to the study of the disease].
García Villarreal L; Zozaya JM; Macías E; García González N; Quiroga J; Conchillo F; Prieto J
Rev Esp Enferm Dig; 1991 Nov; 80(5):311-5. PubMed ID: 1768469
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of primary biliary liver cirrhosis with ursodeoxycholic acid (preliminary report)].
Kolarski V
Vutr Boles; 1991; 30(1):65-70. PubMed ID: 1771866
[TBL] [Abstract][Full Text] [Related]
12. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate.
Kaplan MM; Knox TA
Gastroenterology; 1991 Nov; 101(5):1332-8. PubMed ID: 1936805
[TBL] [Abstract][Full Text] [Related]
14. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine.
Miettinen TA; Färkkilä M; Vuoristo M; Karvonen AL; Leino R; Lehtola J; Friman C; Seppälä K; Tuominen J
Hepatology; 1995 May; 21(5):1261-8. PubMed ID: 7737632
[TBL] [Abstract][Full Text] [Related]
15. A prospective trial of colchicine for primary biliary cirrhosis.
Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease.
Kneppelhout JC; Mulder CJ; van Berge Henegouwen GP; de Vries RA; Brandt KH
Neth J Med; 1992 Aug; 41(1-2):11-6. PubMed ID: 1407234
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
Combes B; Carithers RL; Maddrey WC; Lin D; McDonald MF; Wheeler DE; Eigenbrodt EH; Muñoz SJ; Rubin R; Garcia-Tsao G
Hepatology; 1995 Sep; 22(3):759-66. PubMed ID: 7657280
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.
Wiesner RH; Ludwig J; Lindor KD; Jorgensen RA; Baldus WP; Homburger HA; Dickson ER
N Engl J Med; 1990 May; 322(20):1419-24. PubMed ID: 2184355
[TBL] [Abstract][Full Text] [Related]
19. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
20. Effects of plasma exchange (PE) in primary biliary cirrhosis (PBC). A pilot study.
Surrenti C; Pozzi M; Biagini MR; Franco C; Lombardo R; Avanzi G
Hepatogastroenterology; 1990 Feb; 37(1):128-30. PubMed ID: 2312037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
